Pharmacological Cardioversion With Antazoline in Atrial Fibrillation: The Results of the CANT Study

BACKGROUND: Antazoline mesylate represents an antihistamine capable of rapid and safe cardioversion of atrial fibrillation, yet evidence concerning its efficacy in comparison to other medications is insufficient. The study aimed to evaluate the success rate and safety of pharmacological cardioversio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wybraniec, Maciej T., Wróbel, Wojciech, Wilkosz, Katarzyna, Wrona, Karolina, Bula, Karolina, Mizia‐Stec, Katarzyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474954/
https://www.ncbi.nlm.nih.gov/pubmed/30371270
http://dx.doi.org/10.1161/JAHA.118.010153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474954/
https://www.ncbi.nlm.nih.gov/pubmed/30371270
http://dx.doi.org/10.1161/JAHA.118.010153

Ejemplares similares